University of Pittsburgh spacer UPMC spacer Health Sciences @ Pitt spacer School of Medicine spacer  
University of Pittsburgh Seal Univeristy of Pittsburgh
Department of Immunology
Academic Resources
About Us
Educational Programs
Giving & Development
Employment and Training Opportunities
Flow Facility
Immunology Grant Pre-Review Committee
Thomas E. Starzl Biomedical Science Tower
Phone: 412-383-9737
Fax: 412-383-8098
whiteside_head.jpg Theresa L. Whiteside , Ph.D.
Professor of Pathology
1.27d HCC (Office)
HCC (Lab)
Pittsburgh, PA 
Research Interests
  • Immunology and immunotherapy of human solid tumors
  • Development of anti-cancer vaccines
  • Studies of dendritic cells in cancer
  • Immune monitoring of cancer patients treated with biotherapies
  • Immune suppression in cancer and its mechanisms
  • Cytokines in health and disease
  • B.S. - Columbia University (1962)
  • M.A. - Columbia University (1964)
  • Ph.D. - Columbia University (1967)
Academic Affiliation
  • Professor of Pathology, University of Pittsburgh School of Medicine
  • Professor of Otolaryngology, University of Pittsburgh School of Medicine
  • Director of Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh Health System
Selected Publications
  • Whiteside TL, Gambotto A, Albers A, Stanson J, Cohen EP. Human Tumor-Derived Genomic DNA Transduced into a Recipient Cell Induces Tumor-Specific Immune Responses Ex Vivo. PNAS 99:9415-9420. 2002.
  • Hoffman TK, Donnenberg AD, Finkelstein SD, Donnenberg VS, Friebe-Hoffmann F, Myers EN, Appella E, DeLeo AB, Whiteside TL. Frequencies of Tetramer+ T cells Specific for the Wild-Type Sequence p53264-272 Peptide in the Circulations of Patients with Head and Neck Cancer. Cancer Res 62:3521-3529. 2002.
  • Meidenbauer N, Gooding W, Spliter L, Harris D, Whiteside TL. Recovery of z Chain Expression and Changes in Spontaneous IL-10 Production after PSA-Based Vaccines in Patients with Prostate Cancer. Br J Cancer 86:168-178. 2002.
  • Whiteside TL, Tumor-Induced Death of Immune Cells: its Mechanisms and Consequences. Sem Cancer Biol 12:43-50. 2002.
  • Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL. The Number of Intratumoral Dendritic cells and z-Chain Expression in T Cells as Prognostic and Survival Biomarkers in Patients with Oral Carcinoma. Cancer 91:2136-2147. 2000.
PubMed Link
  • Title: Vaccine Development for Oral Carcinoma
    Agency: NIH
    Role: P.I.
    Funding Period: 1997-2002

  • Title: DNA-based Vaccines for Oral Carcinoma
    Agency: NIH
    Role: P.I.
    Funding Period: 2001-2005

  • Title: Oral Cancer Center at the University of Pittsburgh
    Agency: NIH
    Role: Co-P.I.
    Funding Period: 1999-2004
Lab Personnel
Postdoctoral Fellows
Iris Kuss, M.D.
Taksahi Tsukishiro, M.D., Ph.D.
YongXiang Zhao, M.D., Ph.D.

Research Specialist
Joanna Stanson, M.S.

This website is maintained by the Health Sciences iTarget Team. If you have any technical difficulty please submit your help request here.
Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.
Last Update